Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Tratamiento habitual con formoterol versus tratamiento habitual con salmeterol para el asma crónica: eventos adversos graves

Information

DOI:
https://doi.org/10.1002/14651858.CD007695.pub3Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 14 March 2012see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:

  1. Cochrane Airways Group

Copyright:
  1. Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Christopher J Cates

    Correspondence to: Population Health Sciences and Education, St George's University of London, London, UK

    [email protected]

  • Toby J Lasserson

    Cochrane Editorial Unit, The Cochrane Collaboration, London, UK

Contributions of authors

CJC: conception of the idea and co‐writing of protocol and review.

TL: co‐writing of the protocol and review.

Sources of support

Internal sources

  • St George's University of London, UK.

External sources

  • NIHR, UK.

    Programme Grant

Declarations of interest

None known.

Acknowledgements

We acknowledge the assistance of Susan Hansen in obtaining the papers and extracting study details, Elizabeth Stovold for assistance with the update searches and of Matthew Cates with the protocol, and for input re physiology of beta‐agonist receptors. We thank Prof Haydn Walters for providing editorial review and we thank Linda Armstrong from Novartis for providing data on file for Vervloet 1998 and Gabbay 1998, and Joe Gray of AstraZeneca and Dr Everden for clarifying that there were no deaths in Everden 2004.

CRG Funding Acknowledgement: The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Airways Group.

Disclaimer: The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2012 Mar 14

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events

Review

Christopher J Cates, Toby J Lasserson

https://doi.org/10.1002/14651858.CD007695.pub3

2009 Oct 07

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events

Review

Christopher J Cates, Toby J Lasserson

https://doi.org/10.1002/14651858.CD007695.pub2

2009 Jul 08

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events

Protocol

Christopher J Cates, Toby J Lasserson

https://doi.org/10.1002/14651858.CD007695

Differences between protocol and review

The 'Summary of findings' table was not mentioned in the protocol and has been constructed on the basis of the primary outcomes and asthma‐related SAEs. Adults and children have been described separately in the 'Summary of findings' table.

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.